Sirnaomics is a clinical stage biopharmaceutical company leveraging an outstanding level of knowledge and experience in RNA interference (RNAi) technology to forge a path to high value creation through discovery and development of therapeutics for human disorders with unmet medical needs.



Series E




Org chart

Patrick Y. Lu
Chairman, President & CEO
Nigel Yip
Chief Financial Officer
Michael Molyneaux
Chief Medical Officer
David Mark Evans
Chief Scientific Officer
Dmitry Samarsky
Chief Technology Officer
George Ji
Chief Operation Officer
Monica Zhang
COO, China & Secretary
Xianbin Yang
VP, Chief Scientific Officer - China
Yip Wing Kei
VP, Corporate Finance & CFO, China
Edward Wang
VP, Regulatory Compliance & CTO, China
John Buergenthal
VP, Human Resources
Jacqueline A. Dombroski
VP, Regulatory Affairs
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.